Provided by Tiger Fintech (Singapore) Pte. Ltd.

Irhythm Technologies Inc.

160.58
-1.5200-0.94%
Post-market: 160.45-0.1300-0.08%16:44 EDT
Volume:407.28K
Turnover:65.57M
Market Cap:5.16B
PE:-54.81
High:163.54
Open:163.54
Low:160.27
Close:162.10
52wk High:168.32
52wk Low:55.92
Shares:32.13M
Float Shares:31.75M
Volume Ratio:0.78
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9300
EPS(LYR):-3.6315
ROE:-91.13%
ROA:-3.53%
PB:49.77
PE(LYR):-44.22

Loading ...

iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know

Zacks
·
Mar 18

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Blockhead
·
Mar 11

1 Growth Stock to Target This Week and 2 to Ignore

StockStory
·
Mar 05

Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?

Zacks
·
Feb 26

iRhythm Technologies Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Feb 25

iRhythm Technologies Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
Feb 22

iRhythm Technologies Faces Financial Risks from Convertible Debt Accounting Practices

TIPRANKS
·
Feb 22

IRhythm Technologies Shares Rise After Narrower-Than-Expected 4Q Loss

Dow Jones
·
Feb 22

Irhythm Technologies: Strong Financial Performance and Strategic Advantages Support Buy Rating

TIPRANKS
·
Feb 22

iRhythm price target raised to $145 from $111 at Truist

TIPRANKS
·
Feb 21

Truist Adjusts iRhythm Technologies' Price Target to $145 From $111, Keeps Buy Rating

MT Newswires Live
·
Feb 21

Stock Track | iRhythm Technologies Soars Over 6% on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track
·
Feb 21

iRhythm Technologies Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Feb 21

Stock Track | iRhythm Technologies Soars Over 5% in Pre-market on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track
·
Feb 21

iRhythm Technologies Is Maintained at Buy by Needham

Dow Jones
·
Feb 21

Strong Sales Growth and Strategic Expansion Drive Buy Rating for iRhythm Technologies

TIPRANKS
·
Feb 21

Morgan Stanley Raises Price Target on iRhythm Technologies to $130 From $95, Keeps Overweight Rating

MT Newswires Live
·
Feb 21

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Dynavax (DVAX) and Irhythm Technologies (IRTC)

TIPRANKS
·
Feb 21

CORRECTED-U.S. RESEARCH ROUNDUP-Blue Owl Capital, Insulet, Unity Software

Reuters
·
Feb 21

iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
Feb 21